Dear Colleagues and Friends,

We are delighted to welcome you to the 3^rd Immunotherapy and Cellular Therapy in Cancer (ICTC) International Summit, which will take place March 2-3, 2024 online.

There is a growing and urgent global demand for academic continuing education of hematologists and oncologists. The development of new drugs (targeted therapies, immunotherapy, etc.) is accompanied by a growing demand for sharing experiences in order to improve the quality of patient treatment and care through the development of professional competencies and excellence.

The 2024 ICTC International Summit will cover the following topics, to highlight just a few:

• Indications of CAR-T cells in myeloma
• Indications of CAR-T cells in lymphoma
• Indications of CAR-T cells in ALL
• How I treat CRS
• How I treat ICANS
• CAR-T cells and kidney failure

We are looking forward to welcoming you online over our program days!

Mohamad Mohty, France; Didier Blaise, France; He Huang, China; Arnon Nagler, Israel

On behalf of the IACH Scientific Committee